We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$99.2B
AUM Growth
+$5.03B
(+5.3%)
Cap. Flow
-$3.09B
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
3,988
New
43
Increased
2,065
Reduced
941
Closed
658
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$283M |
| 2 |
Microsoft
MSFT
|
+$139M |
| 3 |
UBS Group
UBS
|
+$131M |
| 4 |
Mercado Libre
MELI
|
+$96.4M |
| 5 |
Alcon
ALC
|
+$66.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$309M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$230M |
| 3 |
Apple
AAPL
|
+$226M |
| 4 |
Alibaba
BABA
|
+$225M |
| 5 |
Morgan Stanley
MS
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 15.57% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Nu Skin
NUS
$267M
| $1.74M | ﹤0.01% |
44,165
+2,295
| +5% | +$95.4K |
|
1902
Theravance Biopharma
TBPH
$877M
| $1.74M | ﹤0.01% |
159,943
+59,718
| +60% | +$631K |
|
1903
TFS Financial
TFSL
$4.93B
| $1.73M | ﹤0.01% |
137,341
+8,730
| +7% | +$122K |
|
|
AVNS
1904
DELISTED
Avanos Medical
AVNS
| $1.73M | ﹤0.01% |
58,213
+2,972
| +5% | +$86.3K |
|
1905
Century Aluminum
CENX
$5.07B
| $1.72M | ﹤0.01% |
172,303
+2,880
| +2% | +$29.8K |
|
1906
Baytex Energy
BTE
$2.92B
| $1.72M | ﹤0.01% |
+459,318
| New | +$1.7M |
|
|
CVAC
1907
DELISTED
CureVac
CVAC
| $1.72M | ﹤0.01% |
246,614
+47,788
| +24% | +$417K |
|
1908
Mesa Laboratories
MLAB
$574M
| $1.72M | ﹤0.01% |
9,833
+669
| +7% | +$120K |
|
1909
Hudbay
HBM
$12.3B
| $1.72M | ﹤0.01% |
327,056
-183,651
| -36% | -$966K |
|
|
VISN
1910
Vistance Networks Inc
VISN
$2.52B
| $1.72M | ﹤0.01% |
269,269
+11,467
| +4% | +$86.8K |
|
1911
Agilysys
AGYS
$3.06B
| $1.71M | ﹤0.01% |
20,755
+439
| +2% | +$35.5K |
|
1912
Core Laboratories
CLB
$521M
| $1.71M | ﹤0.01% |
77,633
+1,414
| +2% | +$33.1K |
|
1913
ReNew
RNW
$2.25B
| $1.71M | ﹤0.01% |
+303,438
| New | +$1.62M |
|
|
ICPT
1914
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.71M | ﹤0.01% |
126,963
-19,247
| -13% | -$333K |
|
1915
WaFd
WAFD
$2.75B
| $1.7M | ﹤0.01% |
56,539
+2,387
| +4% | +$80.7K |
|
1916
Eldorado Gold
EGO
$9.89B
| $1.7M | ﹤0.01% |
163,762
+11,464
| +8% | +$107K |
|
|
DOOR
1917
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.7M | ﹤0.01% |
18,676
+539
| +3% | +$47.5K |
|
1918
Viasat
VSAT
$11.1B
| $1.69M | ﹤0.01% |
50,064
+2,623
| +6% | +$89.5K |
|
1919
The Bancorp
TBBK
$2.9B
| $1.69M | ﹤0.01% |
60,755
+2,982
| +5% | +$94.8K |
|
1920
Par Pacific Holdings
PARR
$3.32B
| $1.69M | ﹤0.01% |
57,894
+1,406
| +2% | +$37.6K |
|
1921
Direxion Daily FTSE China Bull 3X ETF
YINN
$745M
| $1.69M | ﹤0.01% |
35,541
+336
| +1% | +$17.8K |
|
1922
Marqeta
MQ
$1.66B
| $1.69M | ﹤0.01% |
92,342
-20,698
| -18% | -$462K |
|
1923
Delek US
DK
$3.58B
| $1.69M | ﹤0.01% |
73,525
+538
| +0.7% | +$13.5K |
|
1924
Archrock
AROC
$5.8B
| $1.68M | ﹤0.01% |
172,405
+9,272
| +6% | +$90.9K |
|
1925
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $1.68M | ﹤0.01% |
120,996
+27,994
| +30% | +$373K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2023 Portfolio in Review
As of Q1 2023, Credit Suisse held 3,988 positions worth $99.2B, up 5.3% from $94.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Credit Suisse withdrew a net $3.09B in Q1 2023, closing 658 positions and reducing 941 holdings. Its most notable exit was Cresud SACIF y A. Warrant, an estimated $59.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in GE HealthCare worth $34.2M.
- Credit Suisse's largest Q1 2023 buy was GE HealthCare: 417,250 shares worth $34.2M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $283M increase.
- Credit Suisse's biggest Q1 2023 reduction was Amazon, cutting an estimated $309M.
- Credit Suisse fully exited Cresud SACIF y A. Warrant in Q1 2023, selling an estimated $59.2M.
- Credit Suisse's ten largest holdings make up 20% of its $99.2B portfolio in Q1 2023.
- Credit Suisse opened 43 new positions and closed 658 in Q1 2023.
- Credit Suisse's portfolio value rose 5.3% quarter-over-quarter to $99.2B.
Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.